Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

4 registered trials, newest registry update first. Showing only trials linked to VK2735.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)
NCT07868835
VK2735Phase 3RecruitingViking Therapeutics, Inc.560Jul 2028Nov 16, 2026
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)
NCT07868939
VK2735Phase 3RecruitingViking Therapeutics, Inc.560Oct 2028Nov 16, 2026
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
NCT07104383
VK2735Phase 3Active not recruitingViking Therapeutics, Inc.1,100Jul 1, 2027Apr 7, 2026
VK2735 for Weight Management Phase 3
NCT07104500
VK2735Phase 3Active not recruitingViking Therapeutics, Inc.4,500Jul 1, 2027Nov 24, 2025

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.